- Home
- AEHL vs ALZN Comparison
AEHL vs ALZN Comparison
Compare AEHL & ALZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AEHL
- ALZN
- Stock Information
- Founded
- AEHL 1993
- ALZN 2016
- Country
- AEHL China
- ALZN United States
- Employees
- AEHL N/A
- ALZN N/A
- Industry
- AEHL Building Materials
- ALZN Medicinal Chemicals and Botanical Products
- Sector
- AEHL Industrials
- ALZN Health Care
- Exchange
- AEHL Nasdaq
- ALZN Nasdaq
- Market Cap
- AEHL 8.4M
- ALZN 9.0M
- IPO Year
- AEHL 2007
- ALZN 2021
- Fundamental
- Price
- AEHL $3.52
- ALZN $2.20
- Analyst Decision
- AEHL
- ALZN Strong Buy
- Analyst Count
- AEHL 0
- ALZN 1
- Target Price
- AEHL N/A
- ALZN $42.00
- AVG Volume (30 Days)
- AEHL 9.8M
- ALZN 132.8K
- Earning Date
- AEHL 12-26-2025
- ALZN 12-11-2025
- Dividend Yield
- AEHL N/A
- ALZN N/A
- EPS Growth
- AEHL N/A
- ALZN N/A
- EPS
- AEHL N/A
- ALZN N/A
- Revenue
- AEHL $98,773,000.00
- ALZN N/A
- Revenue This Year
- AEHL N/A
- ALZN N/A
- Revenue Next Year
- AEHL N/A
- ALZN N/A
- P/E Ratio
- AEHL N/A
- ALZN N/A
- Revenue Growth
- AEHL 36.99
- ALZN N/A
- 52 Week Low
- AEHL $1.13
- ALZN $1.88
- 52 Week High
- AEHL $11.53
- ALZN $12.11
- Technical
- Relative Strength Index (RSI)
- AEHL 70.78
- ALZN 48.63
- Support Level
- AEHL $1.18
- ALZN $1.88
- Resistance Level
- AEHL $1.34
- ALZN $2.56
- Average True Range (ATR)
- AEHL 0.38
- ALZN 0.18
- MACD
- AEHL 0.28
- ALZN -0.02
- Stochastic Oscillator
- AEHL 84.40
- ALZN 57.35
About AEHL Antelope Enterprise Holdings Limited
Antelope Enterprise Holdings Ltd operates in two reportable operating segments: 1) business management consulting, information system technology consulting services including the sales of software use rights for digital data deposit platforms and asset management systems, and online social media platform development and consulting, and 2) natural gas power generation, which was in the initial development stage. The business of the Company is engaged in the PRC and U.S.
About ALZN Alzamend Neuro Inc.
Alzamend Neuro Inc is an early clinical-stage biopharmaceutical company. It is focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's. Its mission is to develop and market safe and effective treatments. The company's pipeline consists of two novel therapeutic drug candidates, AL001 - a patented ionic cocrystal technology delivering lithium via a therapeutic combination of lithium, proline and salicylate, and AL002 - a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient's immunological system to combat Alzheimer's.